Colorectal cancer and hepatitis synchronous metastases: Should the primary tumor be resected?;Cancer colorectal et métastases hépatiques synchrones: Faut-il toujours réséquer la tumeur primitive?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 5, 2004, Pages 431-432

  Laurent, Christophe ^a   Rullier, Eric ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

CANCER PALLIATIVE THERAPY; CANCER SURGERY; COLORECTAL CANCER; DECISION MAKING; DRUG EFFICACY; EDITORIAL; HUMAN; LIVER METASTASIS; MORBIDITY; MORTALITY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT INDICATION;

EID: 3042584202     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)94951-2     Document Type: Editorial

References (13)

1. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003;90:956-62.
2. Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 2001;78:17-21.
3. de Santibanes E, Lassalle FB, McCormack L, Pekolj J, Quintana GO, Vaccaro C, et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 2002;195:196-202.
4. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233-41.
5. Guimbaud R. Prise en charge thérapeutique des métastases hépatiques des cancers colorectaux. Gastroenterol Clin Biol 2003;27 Spec N° 2:B63-B79.
6. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line, treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-7.
7. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-47.
8. Giachetti S, Bjarnasson G, Garufi C, Tubiana-Mathieu N, Dogliotti L, Lacobelli S, et al. First line infusion of 5-fluorouracil, leucoverin, oxaliplatin for metastastic colorectal cancer chronomodulated versus conventional delivery. A multicenter randomized trial of the EORTC chronotherapy group (abstract). ASCO Annual Meeting (USA) 2002:2231.
9. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-7.
10. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O'Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001;88:1352-6.
11. Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Tenière P, et al. Colorectal cancer with non resectable synchronous metastases: do we need to resect the primary tumour? Gastroenterol Clin Biol 2004;vol:434-437.
12. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347-53.
13. Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003;90:1429-33.